Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer-Reference-Cited by-同舟云学术

Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer

Published:2024-02 Issue:2 Volume:5 Page:101393
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Galsky Matthew D.,Guan Xiangnan,Rishipathak Deepali,Rapaport Aaron S.,Shehata Hesham M.,Banchereau Romain,Yuen Kobe,Varfolomeev Eugene,Hu Ruozhen,Han Chia-Jung,Li Haocheng,Liang Yuxin,Vucic Domagoj,Wang Li,Zhu Jun,Yu Haocheng,Herbst Rebecca H.,Hajaj Emma,Kiner Evgeny,Bamias Aristotelis,De Santis Maria,Davis Ian D.,Arranz José Ángel,Kikuchi Eiji,Bernhard Sandrine,Williams Patrick,Lee Chooi,Mellman Ira,Sanjabi Shomyseh,Johnston Robert,Black Peter C.,Grande Enrique,Mariathasan Sanjeev

Publisher

Elsevier BV

Reference57 articles.

1. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma;Galsky;Ann. Oncol.,2012

2. Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986;De Santis;J. Clin. Oncol.,2012

3. Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours;Sternberg;Eur. J. Cancer,2006

4. Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder;Dash;Cancer,2006

5. Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy;Galsky;J. Clin. Oncol.,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Split-Dose Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Literature Review and Network Meta-Analysis;Clinical Genitourinary Cancer;2024-12

2. Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma;The Oncologist;2024-08-21

3. Reevaluating immunotherapy’s potential in first-line metastatic urothelial carcinoma;Journal of Chemotherapy;2024-08-06

4. Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment;Clinical Cancer Research;2024-07-24

5. Recent Advances of Neoadjuvant Immunotherapy for Urothelial Bladder Cancer;Annals of Surgical Oncology;2024-07-12